Using the ADAM10 specific inhibitor GI254023X, the dual ADAM10/ADAM17 inhibitor GW280264X, or siRNA inhibition of ADAM10 or ADAM17, Wolpert et al. demonstrated increased surface expression of ULBP2 in GBM stem cell lines (55). Here, ADAM17 is linked to glioblastoma.